Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
3
×
life sciences
national blog main
national top stories
amgen
biotech
boston blog main
boston top stories
bristol-myers squibb
ifm therapeutics
merck
national
new york blog main
new york top stories
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
third rock ventures
wisconsin blog main
wisconsin top stories
abeona therapeutics
acadia pharmaceuticals
accent therapeutics
achilles therapeutics
adverum biotechnologies
aimmune
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alk
ally bridge group
What
bio
3
×
drug
3
×
new
pricing
roundup
advanced
advantages
analysis
arrival
award
bar
biotech
bring
brings
cancer
company
data
death
decades
dems
develop
diseases
employing
expect
gamble
genetic
given
goldfinch
immunotherapy
ipo
kidney
later
lead
longer
lung
market
medco’s
medical
medicines
million
Language
unset
3
×
Current search:
drug
×
unset
×
" clinical trials "
×
bio
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone